SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sigyn Therapeutics, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $48.16K
- P/E (TTM)
- –
- Dividend yield
- –
Sigyn Therapeutics statistics
Financials through Sep 30, 2025, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Market Cap | $48.16K | $230.55M |
| Enterprise Value | $3.05M | $202.97M |
Income (trailing twelve months)
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$1.88M | -$4.31M |
| Pretax Income | -$3.22M | -$2.37M |
| Net Income | -$3.22M | -$6.57M |
| EBITDA | -$1.88M | -$1.98M |
| EPS (Diluted) | -$2.01 | -$0.08 |
Returns
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Return on Assets (ROA) | -1144.2% | -13.3% |
Balance sheet
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $85.57K | $36.66M |
| Total Debt | $3.09M | $97.65M |
| Net Cash (Debt) | -$3.00M | $3.92M |
| Net Cash Per Share | -$1.87 | $0.28 |
| Equity (Book Value) | -$5.92M | $55.33M |
| Book Value Per Share | -$3.69 | $2.87 |
| Tangible Book Value | -$5.92M | $10.79M |
| Working Capital | -$3.90M | $56.72M |
Financial position
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 0.02 | 2.48 |
| Quick Ratio | 0.02 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$936.43K | -$566.22K |
Efficiency
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$805.27K | -$51.88K |
| Employee Count | 4 | 185 |
Dividends and yields
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -6688.1% | -6.88% |
Shares
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 1,605,380 | 44,302,700 |
| Shares Change (YoY) | 28.5% | 3.36% |
| Shares Change (QoQ) | 0.00% | 0.27% |
| Float | 1,605,380 | 37,462,700 |
| Shares Held by Insiders | 0.00% | 10.5% |
| Shares Held by Institutions | 3.30% | 63.5% |
Scores
| Measure | Sigyn Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -259.79 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Sigyn Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.